| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |